Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Public ClinicalTrials.gov record NCT00735397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to evaluate the safety and tolerability of perampanel (up to 12 mg/day) given as adjunctive treatment in subjects with refractory partial seizures and to evaluate the maintenance of effect of perampanel for the control of refractory partial seizures.
Study identification
- NCT ID
- NCT00735397
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,218 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2008 (Type not available)
- Primary completion
- Sep 2014 (Actual)
- Completion
- Sep 2014 (Actual)
- Last update posted
- Mar 14, 2016
2008 – 2014
United States locations
- U.S. sites
- 57
- U.S. states
- 29
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Phoenix | Arizona | 85004 | — |
| Not listed | Phoenix | Arizona | 85013 | — |
| Not listed | Tucson | Arizona | 85724 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Fresno | California | 93710 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Ventura | California | 93003 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Fort Collins | Colorado | 80525 | — |
| Not listed | Washington D.C. | District of Columbia | 20010 | — |
| Not listed | Gulf Breeze | Florida | 32561 | — |
| Not listed | Jacksonville | Florida | 32209 | — |
| Not listed | Jacksonville | Florida | 32224 | — |
| Not listed | Orlando | Florida | 32819 | — |
| Not listed | Tallahassee | Florida | 32308 | — |
| Not listed | Tampa | Florida | 33609 | — |
| Not listed | Atlanta | Georgia | 30342 | — |
| Not listed | Suwanee | Georgia | 30024 | — |
| Not listed | Boise | Idaho | 83702 | — |
| Not listed | Indianapolis | Indiana | 46256 | — |
| Not listed | Ames | Iowa | 50010 | — |
| Not listed | Lexington | Kentucky | 40536 | — |
| Not listed | Houma | Louisiana | 70363 | — |
| Not listed | Baltimore | Maryland | 21287-7247 | — |
| Not listed | Bethesda | Maryland | 20817 | — |
| Not listed | Hattiesburg | Mississippi | 39401 | — |
| Not listed | Chesterfield | Missouri | 63017 | — |
| Not listed | Kansas City | Missouri | 64111 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Albany | New York | 12208 | — |
| Not listed | Buffalo | New York | 14222 | — |
| Not listed | Great Neck | New York | 11021 | — |
| Not listed | Lawrence | New York | 11559 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Rochester | New York | 14642 | — |
| Not listed | Syracuse | New York | 13210 | — |
| Not listed | Asheville | North Carolina | 28806 | — |
| Not listed | Akron | Ohio | 44308 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Columbus | Ohio | 43221 | — |
| Not listed | Toledo | Ohio | 43614 | — |
| Not listed | Tulsa | Oklahoma | 74137 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Memphis | Tennessee | 38105 | — |
| Not listed | Dallas | Texas | 75230 | — |
| Not listed | Dallas | Texas | 75235 | — |
| Not listed | Dallas | Texas | 75251 | — |
| Not listed | El Paso | Texas | 79905 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Salt Lake City | Utah | 84108 | — |
| Not listed | Richmond | Virginia | 23298 | — |
| Not listed | Seattle | Washington | 98104 | — |
| Not listed | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 182 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00735397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 14, 2016 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00735397 live on ClinicalTrials.gov.